Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.54, $0.18 better than the analyst estimate of $1.36. Revenue for the quarter came in at $621.86 million versus the consensus estimate of $612.57 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.